Where this fund's issuers are based
73% of weight resolved to an issuer; bonds/private/foreign unresolved issuers excludedAs of February 28, 2025 · N-PORT
Click a bar to list the issuers behind it, ranked by portfolio weight.
State of incorporation (US issuers)
Country of incorporation (non-US issuers)
Principal office state (US)
Principal office country (non-US)
Issuer principal offices
76% of portfolio weight mapped · dot area ∝ portfolio weightIssuers based in
Loading issuers…
| Issuer | Value | % of fund |
|---|---|---|
Largest issuers shown.
Fund contact details
- FundRange Cancer Therapeutics ETF
- Trust / registrantETF Series Solutions (CIK 1540305)
- Principal office 615 EAST MICHIGAN ST, MILWAUKEE, WI 53202
- Phone414-287-3700
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.